» Articles » PMID: 32504417

Cognitive Decline and Modulation of Alzheimer's Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse Hippocampal Neurons

Overview
Journal Mol Neurobiol
Date 2020 Jun 7
PMID 32504417
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs have emerged as regulators of brain development and function. Reduction of miR-101 expression has been reported in rodent hippocampus during ageing, in the brain of Alzheimer's disease (AD) patients and in AD animal models. In this study, we investigated the behavioral and molecular consequences of inhibition of endogenous miR-101 in 4-5-month-old C57BL/6J mice, infused with lentiviral particles expressing a miR-101 sponge (pLSyn-miR-101 sponge) in the CA1 field of the hippocampus. The sponge-infected mouse model showed cognitive impairment. The pLSyn-miR-101 sponge-infected mice were unable to discriminate either a novel object location or a novel object as assessed by object place recognition (OPR) and novel object recognition (NOR) tasks, respectively. Moreover, the sponge-infected mice evaluated for contextual memory in inhibitory avoidance task showed shorter retention latency compared to control pLSyn mice. These cognitive impairment features were associated with increased hippocampal expression of relevant miR-101 target genes, amyloid precursor protein (APP), RanBP9 and Rab5 and overproduction of amyloid beta (Aβ) 42 levels, the more toxic species of Aβ peptide. Notably, phosphorylation-dependent AMP-activated protein kinase (AMPK) hyperactivation is associated with AD pathology and age-dependent memory decline, and we found AMPK hyperphosphorylation in the hippocampus of pLSyn-miR-101 sponge mice. This study demonstrates that mimicking age-associated loss of miR-101 in hippocampal neurons induces cognitive decline and modulation of AD-related genes in mice.

Citing Articles

Application of the Trend of miRNA Expression Levels in APP/PS1 Mice Plasma for the Early Diagnosis of Alzheimer's Disease.

Zhang Y, Wang Y, Zhao F Mol Neurobiol. 2025; .

PMID: 39937416 DOI: 10.1007/s12035-025-04743-6.


Regulation of Zbp1 by miR-99b-5p in microglia controls the development of schizophrenia-like symptoms in mice.

Kaurani L, Islam M, Heilbronner U, Kruger D, Zhou J, Methi A EMBO J. 2024; 43(8):1420-1444.

PMID: 38528182 PMC: 11021462. DOI: 10.1038/s44318-024-00067-8.


The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer's and Parkinson's Diseases.

Taheri A, Golshadi Z, Zare H, Alinaghipour A, Faghihi Z, Dadgostar E Cell Mol Neurobiol. 2024; 44(1):28.

PMID: 38461204 PMC: 10924707. DOI: 10.1007/s10571-024-01461-w.


miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.

Han S, Pyun J, Bice P, Bennett D, Saykin A, Kim S Alzheimers Res Ther. 2024; 16(1):5.

PMID: 38195609 PMC: 10775662. DOI: 10.1186/s13195-023-01366-8.


Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases.

Ma Y, Zhao L Behav Neurol. 2023; 2023:8537296.

PMID: 38058356 PMC: 10697780. DOI: 10.1155/2023/8537296.